Weight Loss · Provider Directory · Updated 2026-05-11
Weight Loss Peptides & Telehealth Providers
Semaglutide, tirzepatide, and other GLP-1 receptor agonists are the cornerstone pharmacotherapy for chronic weight management in 2026. This category covers FDA-approved brand options (Wegovy, Zepbound), compounded telehealth pathways, and emerging molecules (retatrutide, orforglipron).
6 peptides coveredv3.0 rubricUpdated 2026-05-11All 50 states + DC
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11
See the full provider directory for complete profiles, pricing, and v3.0 transparency scoring.
Editorial team
Reviews authored by Dr. Sam Saberian (Lead Medical Researcher), medically reviewed by Alen A. Schwartz, MD, and edited by Julliana Edwards (Editor). About our team →